Share Prices & Company Research

Market News

15 Jan 2021 | 07:51

Indivior says annual revenue, profit to beat expectations

(Sharecast News) - Opioid addiction treatment maker Indivior upped its full-year revenue guidance on Friday and said adjusted pre-tax income is set to beat its previous expectations, thanks in part to better-than-expected revenues from its Sublocade treatment. For the year to the end of December 2020, the company now expects total net revenue of between $645 and $650m, up from previous guidance of $595 to $620m.

Sublocade net revenue is seen at between $128m and $130m, up from previous guidance of $120m to $125m and representing preliminary fourth-quarter net revenue growth of 12% to 18%.

Indivior also highlighted the "relative resilience" of Suboxone Film share through the end of the year, as well as benefits from modest stocking activity in the US in the fourth quarter.

The group said its expectations for Perseris net revenue are consistent with guidance of $12m to $15m.

Indivior is scheduled to release full-year results on 18 February.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.